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Cerebral small vessel disease-related brain lesions such as white matter lesions and lacunes are common ﬁndings of magnetic
resonance imaging in the elderly. These lesions are thought to be major contributors to disability in old age, and risk factors that
include age and hypertension have been established. The radiological, histopathologic and clinical phenotypes of age-related
cerebral small vessel disease remarkably resemble autosomal dominant arteriopathy with subcortical infarcts and leucoence-
phalopathy, which is caused by mutations in NOTCH3. We hypothesized that genetic variations in NOTCH3 also play a role in
age-related cerebral small vessel disease. We directly sequenced all 33 exons, the promoter and 30-untranslated region of
NOTCH3 in 195 participants with either coalescent white matter lesions or lacunes and compared the results to 82 randomly
selected participants with no focal changes on magnetic resonance images in the Austrian Stroke Prevention Study. We detected
nine common and 33 rare single nucleotide polymorphisms, of which 20 were novel. All common single nucleotide polymorph-
isms were genotyped in the entire cohort (n = 888), and four of them, rs1043994, rs10404382, rs10423702 and rs1043997, were
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hypertensives, a result which we replicated in the Cohorts for Heart and Ageing Research in Genomic Epidemiology
Consortium on an independent sample of 4773 stroke-free hypertensive elderly individuals of European descent (P = 0.04).
The 33 rare single nucleotide polymorphisms were scattered over the NOTCH3 gene with three being located in the promoter
region, 24 in exons (18 non-synonymous), three in introns and three in the 30-untranslated region. None of the single nucleotide
polymorphisms affected a cysteine residue. Sorting Intolerant From Tolerant, PolyPhen2 analyses and protein structure simula-
tion consistently predicted six of the non-synonymous single nucleotide polymorphisms (H170R, P496L, V1183M, L1518M,
D1823N and V1952M) to be functional, with four being exclusively or mainly detected in subjects with severe white matter
lesions. In four individuals with rare non-synonymous single nucleotide polymorphisms, we noted anterior temporal lobe
hyperintensity, hyperintensity in the external capsule, lacunar infarcts or subcortical lacunar lesions. None of the observed
abnormalities were speciﬁc to cerebral autosomal dominant arteriopathy with subcortical infarcts and leucoencephalopathy.
This is the ﬁrst comprehensive study investigating (i) the frequency of NOTCH3 variations in community-dwelling elderly and
(ii) their effect on cerebral small vessel disease related magnetic resonance imaging phenotypes. We show that the NOTCH3
gene is highly variable with both common and rare single nucleotide polymorphisms spreading across the gene, and that
common variants at the NOTCH3 gene increase the risk of age-related white matter lesions in hypertensives. Additional
investigations are required to explore the biological mechanisms underlying the observed association.
Keywords: NOTCH3; cerebral small vessel disease; genetics; MRI; ageing
Abbreviations: AGES = Ageing Gene–Environment Susceptibility-Reykjavik Study; ARIC = Atherosclerosis Risk in Communities
Study; CADASIL = cerebral autosomal dominant arteriopathy with subcortical infarcts and leucoencephalopathy; CHARGE = cohorts
for heart and ageing research in genomic epidemiology consortium; NCBI = National Centre for Biotechnology Information;
SIFT = Sorting Intolerant From Tolerant; SNP = single nucleotide polymorphism
Introduction
Correlates of age-related cerebral small vessel disease, such as
white matter lesions and lacunes are common (Launer et al.,
2006), can progress rapidly (Schmidt et al., 2007) and are asso-
ciated with cognitive impairment (Breteler et al., 1994; Longstreth
et al., 2005) to dementia (O’Brien et al., 2003; Vermeer et al.,
2003b), gait disturbances and falls (Rosano et al., 2006; Srikanth
et al., 2009). They are also predictors of future disability (Inzitari
et al., 2009). Besides age and arterial hypertension, causative fac-
tors are widely unknown (O‘Brian et al., 2003). The estimated
heritability index of white matter lesions is in the range of
55–73% (Carmelli et al. 1998; Atwood et al., 2004), which is a
clear indication that genetic factors play a major aetiological
role. Age-related cerebral small vessel disease shows remarkable
radiological and histopathological similarities with cerebral
autosomal dominant arteriopathy with subcortical infarcts and
leucoencephalopathy (CADASIL), a monogenic form of systemic
non-amyloid arteriopathy primarily affecting the brain (Adib-Samii
et al., 2010; Chabriat et al., 1995, 2009; Joutel et al., 1996;
Dichgans et al., 1998; Desmond et al., 1999; Reyes et al., 2009).
CADASIL is caused by mutations in the NOTCH3 gene (Joutel
et al., 1996). Notch3 plays a key role in the functional and struc-
tural integrity of small arteries by regulating vascular smooth
muscle cell differentiation, maturation and phenotypic behaviour
(Artavanis-Tsakonas et al., 1999; Domenga et al., 2004; Wang
et al., 2008). We hypothesized that Notch3 not only plays a role
in CADASIL but is also involved in the development of age-related
cerebral small vessel disease, with both common and rare single
nucleotide polymorphisms (SNPs) of the NOTCH3 gene contribut-
ing to the risk of this multi-factorial disorder. We took a two step
approach to evaluate this hypothesis in the setting of the Austrian
Stroke Prevention Study. First, we screened the promoter, the
coding and the 3’ untranslated region of the NOTCH3 gene for
the presence of mutations in all individuals with either coalescent
white matter lesions or lacunes and compared the frequency of
genetic variants to a random subset of participants from the
Austrian Stroke Prevention Study who were free from focal lesions
on MRI. We then genotyped the whole cohort (n=888) for the
observed common SNPs (minor allele frequency55%) and as-
sessed their association with the presence of white matter lesions
and lacunes as a primary phenotype and white matter lesion pro-
gression as a secondary phenotype. We sought to replicate our
ﬁnding in an independent sample of 8545 stroke-free individuals
of European descent in the Cohorts for Heart and Ageing Research
in Genomic Epidemiology (CHARGE) Consortium including six
community-based cohorts with brain MRI scans and genome-wide
genotype data (Fornage et al., 2011). We further elucidated the
effects of the rare (minor allele frequency 55%) non-synonymous
SNPs in the NOTCH3 gene by studying their association with
CADASIL-speciﬁc clinical and MRI characteristics and by analysing
the possible functionality of non-synonymous SNPs using bioinfor-
matical tools.
Materials and methods
Study population
The Austrian Stroke Prevention Study is a prospective cohort
study on the effects of vascular risk factors on brain structure
and function in cognitively normal middle-aged and elderly
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(Schmidt et al., 1994, 1999). Brieﬂy, participants (n = 2007) were
selected randomly from the ofﬁcial community register and all
participants were free from stroke and dementia. The study proto-
col was approved by the responsible ethics committee. In an initial
study panel that took place between 1991 and 1994, subjects
(n = 509) randomly selected from the entire cohort underwent
an extended diagnostic work-up including brain MRI and cognitive
testing. To enlarge the cohort with imaging and neuropsychologic-
al assessments, an additional 567 individuals were selected
randomly in a second panel between 1999 and 2003. They under-
went identical imaging and cognitive test procedures. Participants
of the ﬁrst and second panels were pooled, which resulted in a
total of 1076 individuals with brain MRI and neuropsychological
evaluation. Clinical history, blood tests, MRI and cognitive assess-
ments were always performed on the same day. Historic informa-
tion and laboratory ﬁndings at baseline were considered for risk
factor diagnosis. The deﬁnitions have previously been described
(Schmidt et al., 1999). A history of migraine was taken in all
study participants and all individuals underwent dementia screen-
ing by the Mini-Mental State Examination (Folstein et al., 1975).
For assessment of depressive mood, we applied the
‘Eigenschaftswo ¨rterliste’, a validated multi-dimensional tool con-
sisting of a list of given adjectives describing the emotional state
of a person (Janke, 1978). In the present study, 888 participants
of the Austrian Stroke Prevention Study with brain MRI and DNA
samples were included. Their mean age was 65.2   8.0 years.
There were 505 (56.9%) women. Mean systolic blood pres-
sure from three measurements taken during clinical examination
was 143.8   23.16mmHg (range 85–220), mean diastolic
blood pressure was 87.7   10.32 mmHg (range 60–123).
Hypertensives were deﬁned as having a mean systolic blood pres-
sure 5140 mmHg or a diastolic blood pressure 590 mmHg or
being on anti hypertensive therapy. A total of 641 (72.2%) par-
ticipants were hypertensive and 251 (23.3%) were on antihyper-
tensive therapy. In total, 86 (9.7%) had diabetes and 304 (34.2%)
had cardiac disease based on clinical, ECG and echocardiography
results. Altogether, 152 (17.1%) subjects reported migraine and
91 (10.2%) reported depressed mood. The mean Mini-Mental
State Examination score of the sample was 27.4   1.7. At least
one follow-up examination at 3 and 6 years with identical proto-
cols was carried out in 534 subjects. There were 500 and 300
subjects with 3- and 6-year follow-up MRI scans, respectively.
Magnetic resonance imaging
All scans were obtained on a 1.5 Tesla scanner (Philips Medical
Systems) with protocols described previously (Schmidt et al.,
1999). White matter lesion grade, volume and lacunes were deter-
mined in each study participant at baseline and follow-ups. White
matter lesions were assessed by two experienced investigators
(R.S. and C.E.). There were 717 (80.7%) participants with white
matter lesions of any grade. In total, 195 (21.9%) subjects had
early conﬂuent or conﬂuent lesions. The methods used for volume
measurements have been described elsewhere (Schmidt et al.,
1999, 2005). Mean white matter lesion load was 3.04cm
3
(range 0–78) at baseline investigation. The annual change of
white matter lesion volume was calculated by dividing the volume
change by years of follow-up. The mean annual change in white
matter lesion load observed in our study participants was 0.22cm
3
(range 0–4.99). Lacunes were deﬁned as focal lesions that
involved the basal ganglia, internal capsule, thalamus or brain-
stem, not exceeding a maximum diameter of 15mm and occurred
in 80 (9.2%) subjects. Incident lacunes at any follow-up were
determined by direct comparison of baseline and follow-up
scans. Incident lacunes were seen in 10 (2.0%) study participants.
In carriers of rare non-synonymous SNPs, MRI images were also
reviewed for ﬁndings suggestive of CADASIL. These included
anterior temporal lobe hyperintensity, hyperintensity of the exter-
nal capsule and subcortical lacunar lesions (Markus et al., 2002;
van den Boom et al., 2003). As in subjects with common SNPs,
we also recorded lacunes, white matter lesion volume at baseline
and annual progression of lesions in this subset of participants.
Microbleeds could not systematically be assessed as only a small
portion of participants in the Austrian Stroke Prevention Study
underwent MRI with gradient echo sequences.
DNA analyses
DNA sampling
Genomic DNA was extracted from ethylenediaminetetraacetic
acid–blood using the standard phenol/chloroform method. A por-
tion of the genomic DNA was ampliﬁed by REPLI-g Screening Kit
(QIAGEN) and was used as template for the mutation screening.
The original genomic DNA was used for conﬁrmatory sequencing
of detected SNPs and for genotyping the common SNPs using the
TaqMan assay.
Mutation screening
The promoter, all 33 exons (including the intronic ﬂanking regions)
and 30-untranslated regions were ampliﬁed by PCR in separate
reactions. Exon 24 was subdivided into two overlapping PCRs
(24–1, 24–2) and exon 33 into 6 overlapping PCRs (33–1, 33–6).
The PCR products were then puriﬁed with Wizard SV Gel and
PCR Clean-up kit as prescribed by Promega, veriﬁed by gel electro-
phoresis and sequenced using BigDye Terminator v1.1 Cycle
Sequencing (Applied Biosystems) on a 3730 DNA Analyser (Applied
Biosystems/HITACHI). All reagents, PCR primers and conditions are
given in the Supplementary material. Electropherograms were ana-
lysed with the SeqScape v2.5 (Applied Biosystems) and the
Sequencing Analysis 5.2 (Applied Biosystems) algorithms. The mes-
senger RNA sequence of the National Centre for Biotechnology
Information (NCBI; accession number NM_000435, version
NM_000435.2) was used as the reference sequence and for num-
bering of mutations at the DNA level. The corresponding amino
acid sequence originated from GenBank (accession number
U97669, version U97669.1), positions of the mutations are
given related to the ATG translation start site at the protein level.
For the ﬁnal annotation of detected common SNPs, The Single
Nucleotide Polymorphism database of the NCBI was used
(www.ncbi.nlm.nih.gov/SNP/). All samples showing a sequence
alteration during the screening procedure were resequenced
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order to deﬁne mutations with high conﬁdence.
Genotyping of common single nucleotide
polymorphisms
Real-time PCR with sequence-speciﬁc TaqMan probes (Ingenetix;
Vienna, Austria) were used for genotyping common SNPs (minor
allele frequency 55%; rs11882186, rs1043994, rs61749020,
rs10423702, rs1043996, rs1043997, rs1044006, rs4809030 and
rs1044009) in 888 participants of the Austrian Stroke Prevention
Study cohort for whom both MRI and DNA samples were avail-
able. TaqMan assays were analysed on a 7900HT Fast Real-time
PCR system (Applied Biosystems). Detailed genotyping conditions
are given in the Supplementary material. One common SNP at the
NOTCH3 gene, rs10404382, was genotyped earlier on the Illumina
Human610-Quad BeadChip and was also included in the analyses.
Functional assessment of rare single
nucleotide polymorphisms
Sorting Intolerant From Tolerant and PolyPhen2
The Sorting Intolerant From Tolerant (SIFT) algorithm (J. Craig
Venter Institute, version 4.0.3) was used to predict whether
rare SNPs affect the Notch3 protein function. SIFT uses sequence
homology for calculating whether an amino acid substitution at a
given position is tolerated or affects the protein function.
Substitutions are more tolerated at positions with low conserva-
tion and more intolerant with high conservation. In order to get
related homologous sequences for the input query sequence, a
Basic Local Alignment Search Tool search was performed using
the NCBI non-redundant database. Only related sequences with a
maximum identity percentage of 90 were used for this analysis.
SIFT is available at http://sift.jcvi.org.
PolyPhen2, a revised version of PolyPhen, allows prediction of
the impact of missense mutations on the function of encoded
proteins by performing various sequence and structure analyses,
yielding a probability of altered function. We have used the data
set HumDiv to test and train the predictions made by PolyPhen2.
Predictions are characterized as either benign, possibly damaging
or probably damaging on the output. PolyPhen2 is available at
http://genetics.bwh.harvard.edu/pph2.
Protein simulation by homology
modelling and threading
The 3D structure of Notch3 was not available in the Protein Data
Bank database (Sussman, 1999). Therefore, parts of the structure
have been determined by homology modelling and threading.
Homology modelling is a knowledge-based structure prediction
where a protein sequence with an unknown structure (the target)
is aligned with one or more protein sequences with known struc-
tures (the templates). By the threading method, the sequence with
an unknown structure is ﬁtted into a variety of existing structures.
The model building can be done by using proﬁle–proﬁle matching
and secondary structure. The homology modelling was done with
SWISS-MODEL and the threading with Phyre (Protein HomologY
Recognition Engine), a successor of 3D-PSSM (Kelley and
Sternberg, 2009). To study putative structural effects of the
mutations, the affected residues inside the domains of Notch3
were interchanged and an energy minimization was performed.
These replacements were performed on the Swiss-Pdb viewer
(Guex and Peitsch, 1997). The structural changes due to the mu-
tations are visualized and the energy of the molecular force ﬁeld
(GROMOS96 force ﬁeld) calculated (Li et al., 2008).
Statistical analyses
Genotypes were coded according to the minor alleles as 0 for
homozygous for the major allele, 1 for heterozygous and 2 for
homozygous for the minor allele. All common SNPs were tested
for Hardy Weinberg equilibrium. The linkage disequilibrium plot
was drawn using common SNPs genotyped in the Austrian
Stroke Prevention Study cohort by HaploView 4.2 (Barrett et al.,
2005) using the standard (D0/LOD) linkage disequilibrium colour
scheme. Linkage disequilibrium values are given by R
2. The haplo-
type blocks were estimated using the ‘solid spine of LD’ method,
which deﬁnes haplotype blocks by the ﬁrst and the last SNPs
being in strong linkage disequilibrium with all intermediate mark-
ers. Linkage disequilibrium does not necessarily appear between
intermediate SNPs. Linear trend test with 1 degree of freedom was
used to assess the effect of genotypes on the presence of white
matter lesions and lacunes assuming additive genetic effects.
Logistic regression analyses were used to assess the association be-
tween the common SNPs and the presence of white matter lesions
as well as lacunes upon adjustment for age (Model 1) and age,
sex, hypertension, cardiac disease and diabetes (Model 2).
Multiple linear regressions were used to assess the effect of com-
mon SNP genotypes on the annual change of white matter lesion
volume, as measure of white matter lesions progression upon ad-
justment for age (Model 1) and age, sex, hypertension, cardiac
disease and diabetes (Model 2). Both regression analyses were also
conducted with stratiﬁcations for hypertension (yes/no).
Replication
The replication sample comprised 8545 individuals of European des-
cent (aged 69.5 years; 42.6% men) belonging to six community-
based cohort studies including the Ageing Gene–Environment
Susceptibility-Reykjavik Study (AGES); the Atherosclerosis Risk in
Communities (ARIC) Study; the Cardiovascular Health Study; the
Framingham Heart Study; and two cohorts from the Rotterdam
Study. All studies collaborated within the CHARGE consortium neur-
ology working group. Details of the goals and organization of the
CHARGE consortium have previously been described (Psaty et al.,
2009). A total of 4773 hypertensive (AGES: 1959, ARIC: 157,
Cardiovascular Health Study: 1082, Framingham Heart Study: 940,
Rotterdam Study I: 269, Rotterdam Study II: 366) and 3772 normo-
tensive (AGES: 508, ARIC: 633, Cardiovascular Health Study: 1102,
Framingham Heart Study: 1218, Rotterdam Study I: 111, Rotterdam
Study II: 200) individuals were included in the present analyses.
Details of cohort selection, risk factor assessment and white matter
lesion assessment in each study, as well as genotyping procedures,
have been described (Fornage et al., 2011) and are given in more
detail in the Supplementary material. Brieﬂy, each study performed
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sive quality control all studies used their genotype data to impute
to the 2.5 million non-monomorphic, autosomal SNPs described in
the HapMap’s CEU (Utah residents with Northern and Western
European ancestry from the Centre de’Etude du Polymorphism
Humain collection) panel. The MRI scan protocol to detect white
matter lesions either used a ﬂuid attenuation inversion recovery
sequence or proton density sequences. In participants from the
AGES-Reykjavik, Framingham Heart Study and Rotterdam Study,
white matter lesion volume was estimated on a quantitative scale
using custom written computer programmes based on an auto-
matic segmentation algorithm or a semi-automatic segmentation
analysis, in participants of the ARIC and Cardiovascular Health
Studies, white matter lesion volume was estimated on a
semi-quantitative scale. Within each study, a linear regression
model was used to evaluate the association of the SNP with the
natural log-transformed volume of white matter lesions. The
CHARGE consortium used the term white matter hyperintensity
as a synonym for white matter lesions. An additive genetic
model was assumed and signiﬁcance of association was estimated
using a 1 degree of freedom trend test relating genotype dosage,
zero to two copies of the minor allele, to the phenotype. Analyses
were adjusted for age, sex and total intra-cranial volume (except
in the ARIC and Cardiovascular Health Studies, which inherently
adjust for intracranial volume). In addition, the ARIC and
Cardiovascular Health Studies adjusted for study site, and the
Framingham Heart Study adjusted for familial structure. Within
each study, analyses were performed separately in normo- and
hypertensives. Fixed-effect meta-analyses with inverse variance
weighting and forest plots were done according to hypertension
status using the Comprehensive Meta Analysis Version 2.2 soft-
ware (Borenstein et al., 2009). For estimating heterogeneity,
Cochran’s Q and I
2 statistics were calculated.
Results
NOTCH3 sequence variations
We sequenced the NOTCH3 gene including the promoter, all
33 exons with the intronic ﬂanking regions and the 30-untranslated
region in all 195 participants of the Austrian Stroke Prevention
Study with early conﬂuent or conﬂuent white matter lesions
or lacunes and in 82 randomly selected participants with normal
MRI. We found 42 SNPs scattered over the gene, with four
located in the promoter region, 30 in exons (19 non-synonymous,
11 synonymous), ﬁve within introns and three in the 30-untrans-
lated region. None of the SNPs affected a cysteine residue. In 13
exons, we did not detect mutations. According to the functional
domains of the Notch3 protein, 18 SNPs (11 non-synonymous,
seven synonymous) were in the epidermal growth factor-like re-
peats, two SNPs (one non-synonymous, one synonymous) in the
Lin12/Notch repeat domain, three (two non-synonymous, one
synonymous) in the Notch domain, one non-synonymous SNP in
the transmembrane domain, three SNPs (two non-synonymous,
one synonymous) in the ankyrin repeats domain and three (two
non-synonymous, one synonymous) in the low complexity region
domain. The distribution of SNPs over the NOTCH3 gene and
protein is shown in Fig. 1.
Common single nucleotide
polymorphisms and magnetic
resonance imaging ﬁndings
Among the 42 SNPs, nine had a minor allele frequency minor
allele frequency 55% in the subset of individuals with normal
MRI. All of these common SNPs were described in the Single
Nucleotide Polymorphism database and their characteristics are
given in Supplementary Table 1. All common SNPs, except for
rs1044009, which was excluded from further analyses, were in
Hardy Weinberg equilibrium. Linkage disequilibrium among the
SNPs in our cohort is shown in Fig. 2. We investigated the asso-
ciation between common SNPs and the presence of white matter
lesions and lacunes by assuming an additive genetic effect for the
minor alleles at each SNP (Supplementary Table 2). Carriers of the
minor allele at SNPs rs1043994, rs10404382 and at rs10423702
more commonly had white matter lesions. White matter lesions
were seen in 532 (79.2%) AA, 160 (85.1%) AG and 16 (94.1%)
GG genotype carriers, at rs1043994 (P = 0.022); in 488 (80.5%)
AA, 155 (87.1%) AC and 13 (92.9%) CC genotype carriers at
rs10404382 (P = 0.022); and in 535 (79%) individuals with the
Figure 1 Distribution of detected single nucleotide polymorphisms over the promoter region, exons and 30-untranslated region of the
NOTCH3 gene. Corresponding protein domains shown below. Functional annotation of mutations is colour coded: red
star = non-synonymous mutation; blue star = synonymous mutations; orange star = non-synonymous mutation occurring only in par-
ticipants with white matter lesions; green star = synonymous mutation occurred only in participants with white matter lesions; black
star = mutation in promoter region, 30 untranslated region and introns, respectively. ANK = ankyrin repeats; EGFR = epidermal growth
factor-like repeat; LCR = low complexity region; LNR = Lin12/Notch repeat; NOD = Notch domain; Prom = promoter;
RAM = RBP-J-associated molecule domain; TMD = transmembrane domain; 30-UTR = 30-untranslated region.
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genotype at rs10423702 (P = 0.015). Logistic regression analysis
with adjustment for age (Model 1) and adjustment for
age, gender, hypertension, diabetes and cardiac disease (Model
2) revealed four of the common SNPs—rs1043994, s10404382,
rs10423702 and rs1043997—to be signiﬁcantly related to the
presence of white matter lesions (Table 2). Stratiﬁcation of the
analysis by the presence of hypertension showed that the effect
of the four SNPs was only present in hypertensives but not in
normotensives. As shown in Table 2, odds ratios were in the
range 2.1–3.4 for the presence of one minor allele at these
SNPs in hypertensives (P50.01), while there was no signiﬁcant
association in normotensives. The frequency of white matter le-
sions over the genotypes upon stratiﬁcation is given in the
Supplementary material. As can be seen in Table 3, the SNPs
were not only associated with the presence, but also with the
progression of white matter lesions. The effect was strongest in
subjects with hypertension. Importantly, the size and strength of
the association changed only marginally when additional adjustment
for baseline white matter lesions load was done (rs1043994:
b = 0.125; P = 0.07; rs10404382: b = 0.142; P = 0.05; rs10423702:
b = 0.141; P = 0.04; rs1043997: b = 0.087; P = 0.2). None of the
SNPs showed associations with the presence of lacunes
(rs1043994: odds ratio = 1.05, P = 0.89; rs10404382: odds
ratio = 1.21, P = 0.44; rs10423702: odds ratio = 1.03, P = 0.89;
rs1043997: odds ratio = 1.16, P = 0.54).
Replication study
We sought to replicate our results on the SNP rs10404382, which
was associated with the highest risk for white matter lesions in the
Austrian Stroke Prevention Study cohort, within the CHARGE con-
sortium including the AGES, ARIC, Cardiovascular Health Study,
Framlingham Heart Study and Rotterdam Studies I and II. There
were 4773 hypertensive (AGES: 1959, ARIC: 157, Cardiovascular
Health Study: 1082, Framlingham Heart Study: 940, Rotterdam
Study I: 269, Rotterdam Study II: 366) and 3772 normotensive
(AGES: 508, ARIC: 633, Cardiovascular Health Study: 1102,
Framingham Heart Study: 1218, Rotterdam Study I: 111,
Rotterdam Study II: 200) stroke-free elderly individuals involved in
the replication. Figure 3 displays the results of the meta-analyses
in the form of forest plots in these two subgroups as well as the
study-speciﬁc b-coefﬁcients and 95% conﬁdence intervals (95%
CIs). The C allele (allele frequency = 0.12; range = 0.11–0.16)
increased white matter lesions burden in hypertensives (P = 0.04;
b = 0.039; 95% CI 0.002; 0.076 on the transformed log
scale), but not in normotensives (P = 0.89; b = 0.002; 95% CI
 0.028 to 0.033). The effect in hypertensives corresponds
to an increase of 3.5% of the overall mean white matter lesions
burden by one risk allele. There was no evidence of sub-
stantial between study heterogeneity in either subgroups (normoten-
sives: Cochran’s Q = 4.183, P =0 . 5 3 , I
2= 0.00; hypertensives:
Cochran’s Q = 7.59, P = 0.18, I
2 = 34.15). At the individual study
Figure 2 Linkage disequilibrium plot of common single nucleotide polymorphisms together with inferred haplotype blocks. (Top)
Distribution of common SNPs on chromosome 19 over the NOTCH3 gene. The linkage disequilibrium values are R-squared with standard
(D0/LOD) colour scheme. Each black triangle depicts haplotype blocks.
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(P = 0.014; b = 0.108; 95% CI 0.022–0.194), and Cardiovascular
Health Study (P = 0.029; b = 0.62; 95% CI 0.006–0.118) repre-
senting the largest and oldest cohorts.
Clinical characteristics of rare single
nucleotide polymorphism carriers
We detected 33 rare SNPs (minor allele frequency 55%) includ-
ing 20 SNPs, which have not been described previously. As shown
in Table 4, three SNPs were located in the promoter region, 24 in
exons, three in introns and three in the 30-untranslated region.
Altogether, eight rare SNPs were C to T transitions at CpG di-
nucleotides. The 24 exonic SNPs included 18 non-synonymous
and six synonymous mutations. Fourteen SNPs were located in
epidermal growth factor-like repeats, two in Lin12/Notch repeat
domains, two in the Notch domain, one in the transmembrane
domain, three in the ankyrin repeat domains and two in the low
complexity region domain of Notch3. Of these SNPs, 15 were
exclusively detected in participants with severe white matter le-
sions, one in the promoter region, 11 in exons, one in an intron
and two in the 30-untranslated region. Importantly, nine of them
were non-synonymous SNPs. Clinical characteristics of the carriers
of these nine are shown in Table 5. All were 465 years, and with
one exception all had hypertension. In all subjects who underwent
repeated MRI scanning, white matter lesions progression was
observed. Temporal lobe hyperintensity, hyperintensity in the ex-
ternal capsule, lacunar infarcts or subcortical lacunar lesions were
seen in four of the nine individuals. None of these signal changes
Table 1 Association between common single nucleotide
polymorphisms and the presence of white matter lesions in
the Austrian Stroke Prevention Study cohort
SNP ID Minor
allele
Minor
allele
frequency
n Odds ratio
(95% CIs)
P-value
rs11882186
a T 12.5 851 1.083 (0.720–1.630) 0.702
rs11882186
b T 12.5 851 1.051 (0.694–1.591) 0.814
rs1043994
a G 12.7 877 1.677 (1.093–2.572) 0.018
rs1043994
b G 12.7 877 1.730 (1.121–2.669) 0.013
rs10404382
a C 12.9 798 1.751 (1.100–2.786) 0.018
rs10404382
b C 12.9 798 1.801 (1.127–2.879) 0.014
rs61749020
a C 5.1 857 1.075 (0.606–1.908) 0.804
rs61749020
b C 5.1 857 1.099 (0.615–1.964) 0.749
rs10423702
a G 12.5 882 1.700 (1.103–2.621) 0.016
rs10423702
b G 12.5 882 1.727 (1.114–2.676) 0.015
rs1043996
a C 28.1 795 1.130 (0.835–1.530) 0.428
rs1043996
b C 28.1 795 1.154 (0.850–1.567) 0.358
rs1043997
a G 13.5 885 1.483 (0.998–2.201) 0.051
rs1043997
b G 13.5 885 1.510 (1.013–2.249) 0.043
rs1044006
a A 12.6 833 1.006 (0.690–1.467) 0.976
rs1044006
b A 12.6 833 1.033 (0.705–1.514) 0.867
rs4809030
a T 10.1 850 1.355 (0.846–2.171) 0.206
rs4809030
b T 10.1 850 1.417 (0.879–2.284) 0.152
Odds ratios and P-values are given for the effect of the minor alleles, signiﬁcant
SNPs are highlighted in bold.
a Logistic regression analyses Model 1 including age and the corresponding SNP.
b Logistic regression analyses Model 2 including age, sex, hypertension status,
diabetes status and the corresponding SNP.
n = number of successfully genotyped individuals; SNP ID = Identiﬁcation number
of SNPs according to the Single Nucleotide Polymorphism database. Available
from: http://www.ncbi.nlm.nih.gov/SNP/
Table 2 Association of common single nucleotide polymorphisms with the presence of white matter lesions in
normotensive and hypertensive individuals
SNP ID Normotensives Hypertensives
n Odds ratio (95% CI) P-value n Odds ratio (95% CI) P-value
rs1043994 243 1.08 (0.571–2.044) 0.813 634 2.503 (1.342–4.667) 0.004
rs10404382 224 0.933 (0.482–1.896) 0.836 573 3.239 (1.559–6.728) 0.002
rs10423702 244 1.070 (0.558–2.054) 0.838 637 2.467 (1.324–4.598) 0.004
rs1043997 247 0.995 (0.558–1.776) 0.987 637 2.148 (1.204–3.834) 0.010
Signiﬁcant SNPs are highlighted in bold. Odds ratios and P-values are given for the presence of one minor allele at the corresponding SNPs after adjustment for age, sex,
diabetes status and cardiac disease by logistic regression analyses.
n = number of successfully genotyped individuals; SNP ID = Identiﬁcation number of SNP according to the Single Nucleotide Polymorphism database.
Table 3 The effect of common single nucleotide polymorphisms on white matter lesion progression measured as annual
white matter lesions load change in the Austrian Stroke Prevention Study cohort and hypertensive individuals
SNP ID Austrian Stroke Prevention Study cohort Hypertensives
n b (95% CI) P-value n b (95% CI) P-value
rs1043994 484 0.087 (0.000 to 0.238) 0.05 319 0.136 (0.043 to 0.365) 0.013
rs10404382 446 0.082 ( 0.018 to 0.235) 0.091 296 0.147 (0.053 to 0.392) 0.010
rs10423702 485 0.092 (0.007 to 0.247) 0.038 319 0.143 (0.055 to 0.198) 0.009
rs1043997 488 0.051 ( 0.046 to 0.180) 0.246 320 0.096 ( 0.016 to 0.304) 0.078
Signiﬁcant SNPs are highlighted in bold. b-Coefﬁcients and P-values are given for the presence of one minor allele at the corresponding SNPs after adjustment for age, sex,
hypertension (only in the entire cohort), diabetes status and cardiac disease by linear regression analyses.
n = number of successfully genotyped individuals; SNP ID = Identiﬁcation number of SNP according to the Single Nucleotide Polymorphism database.
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lesion at the right temporal lobe because it is located adjacent to
the ventricular horn and does not affect the temporopolar white
matter, which is strongly associated with CADASIL (Fig. 4A).The
subject with the V764A variant showed not only the most pro-
nounced white matter lesion load and progression, but also had
slight anterior temporal lobe hyperintensity, considered to be a
speciﬁc MRI ﬁnding in CADASIL cases (Fig. 4A). Another individ-
ual with an A1450T exchange did not have anterior temporal lobe
hyperintensity, but had three other MRI ﬁndings suggestive of
CADASIL (Fig. 4B and C). Migraine without aura was reported
by one subject carrying the L1518M mutation. The Mini-Mental
State Examination score was within normal range in all
non-synonymous rare SNP carriers and there was no indication
of depression in these individuals. Stroke in ﬁrst-degree relatives
was reported by two subjects with the H170R and S497L
mutations.
Functional assessment of rare
non-synonymous single nucleotide
polymorphisms
We assessed the functionality of the detected non-synonymous
rare SNPs by SIFT, PolyPhen2 and by homology modelling and
threading (Table 6). Using SIFT, eight amino acid substitutions—
H170R, P496L, V764A, H1133Q, V1183M, L1518M, D1823N
and V1952M—reached the optimum median sequence conserva-
tion values with scores between 0.00 and 0.05 and were predicted
to affect the protein function. Also, the A2190V substitution was
predicted to be functional but with low conﬁdence. The SIFT
scores for the amino acid substitutions S497L, R1262L, A1450T
and G1710D, ranged between 0.06 and 0.87 and were predicted
as being tolerated. PolyPhen2 predicted H170R, A1450T, L1518M
and V1952M as probably damaging, and P496L, V1183M,
G1710D and D1823N as possibly damaging to protein function.
The method of homology modelling and threading to simulate
protein structure alterations upon mutation showed possible func-
tionality for the mutations H170R, P496L, S497L, V1183, R1262L,
A1450T, L1518M, D1823N and V1952M (Supplementary
Figs 1–9). Due to the different chemical and physical properties
of the replaced amino acids, the protein functionality could be
altered. Altogether there were six SNPs, H170R, P496L,
V1183M, L1518M, D1823N and V1952M, implicated by all
three bioinformatical tools as functional. Except for two of these
SNPs (V1183M and V1952M), they were exclusively or mainly
detected in subjects with severe white matter lesions. Table 6
summarizes the results of the functional SNP assessments.
Discussion
This is the ﬁrst study investigating the distribution of sequence
variations in the NOTCH3 gene and assessing their role in
age-related cerebral small vessel disease in a community-based
cohort. We show that NOTCH3 is highly variable in the elderly
with both common and rare SNPs across the gene. Importantly,
mutations affecting cysteine residues, a characteristic of CADASIL
(Chabriat et al., 2009), were absent in the Austrian Stroke
Prevention Study cohort. Four common SNPs in strong linkage
disequilibrium signiﬁcantly enhanced the risk for both the presence
and progression of white matter lesions. Importantly, the effect of
SNPs on both phenotypes was conﬁned to hypertensives. We
found that the SNP, rs10404382, showing the strongest effect
on white matter lesions risk in the Austrian Stroke Prevention
Study cohort, was also signiﬁcantly associated with white matter
lesions burden in an independent sample of 4773 elderly hyper-
tensive stroke-free individuals of European descent within the
CHARGE consortium, including the AGES, ARIC, Cardiovascular
Health Study, Framingham Hear Study and Rotterdam Studies I
and II. We observed nine rare non-synonymous SNPs, which were
only present in subjects with severe white matter lesions.
Bioinformatical tools consistently implicated three of these SNPs
to be functional. Clinical assessment of the carriers of the nine
SNPs did not reveal CADASIL-speciﬁc ﬁndings. Beside white
Figure 3 Forest plots for the single nucleotide polymorphism
rs10404382 within the CHARGE consortium in normotensives
(Panel A) and in hypertensives (Panel B). Individual studies
are plotted against the individual effect sizes (point estimates
of the b-coefﬁcients for white matter lesions as continuous trait,
log transformed). The size of the box is inversely proportional to
the estimated variance of the effect-size estimator. Horizontal
lines are the 95% CIs. The diamond represents the meta-analytic
effect size. AGES = Aging Gene-Environment Susceptibility-
Rejkjavik Study; ARIC = Atherosclerosis Risk in Communities
Study; CHS = Cardiovascular Health Study; FHS = Framingham
Heart Study; RS = Rotterdam Study.
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intensity in the external capsule, lacunar infarcts and subcortical
lacunar lesions in four, the presence of migraine in one and stroke
in ﬁrst-degree relatives of two individuals. Although such ﬁndings
have been reported in cases of CADASIL, it is important to realize
that the lesion at the anterior temporal lobe was not typical for the
disease as it did not affect the temporopolar white matter. All
other MRI lesion types also occur in elderly subjects without
CADASIL. Additionally, subjects with migraine had no aura,
which would be more indicative for CADASIL.
Of particular interest is our ﬁnding indicating hypertension-de-
pendent effects of NOTCH3 variants on both prevalence and pro-
gression of white matter lesions. It is conceivable that the
association is mediated by an impaired vascular response to hyper-
tension due to Notch3 dysfunction. In the adult brain, Notch3 is
expressed in the vascular smooth muscle cells of small vessels and
it is essential for maintaining normal vascular structure and func-
tion (Ayata, 2010; Joutel et al., 2010). Furthermore, it also plays a
central role in the autoregulation of cerebral blood ﬂow and cere-
bral resistance (Joutel et al., 2010). Autoregulation assures that
under ﬂuctuating blood pressure, cerebral blood ﬂow remains ad-
equate. The white matter is particularly sensitive to ischaemia
(Pantoni et al., 1996) and white matter lesions are thought
to be ischaemic manifestations of chronic hypoperfusion with de-
generation of myelinated ﬁbres due to repeated selective oligo-
dendrocyte death (Pantoni, 2010). In this context, it is important
to note that not only hypertension, but also diurnal blood pres-
sure abnormalities have been shown to be associated with
white matter lesions (Gomez-Angelats et al., 2004). NOTCH3
knockout mice showed an enhanced susceptibility to ischaemia
Table 4 List and characteristics of rare single nucleotide polymorphisms
SNP ID cDNA Allele Exon Function Amino acid
change
Domain Novel WML
+,
n = 195
WML
 ,
n =8 2
1  622 C / T Prom 50 near gene – – No 0 1
2  462 G / C Prom 50 near gene – – No 1 0
3  328 A / C Prom 50 near gene – – No 1 3
4 274+16 G / A 2 intron – – No 0 1
5
a 384 G / A 3 NS R103Q EGFR 2 Yes 0 1
6 585 A / G 4 NS H170R EGFR 4 Yes 1 0
7 847 C / A 5 S T257T EGFR 6 Yes 0 1
8 1563 C / T 9 NS P496L EGFR 12 No 8 2
9
a 1566 C / T 9 NS S497L EGFR 12 Yes 1 0
10 1581 C / T 10 NS S502F EGFR 12 Yes 0 1
11
a 1717 C / T 11 S G547G EGFR 14 Yes 1 0
12
a 1801 G / A 11 S T575T EGFR 14 No 6 1
13 2367 T / C 14 NS V764A EGFR 19 Yes 1 0
14 2486 + 452 C / G 15 Intron – – No 2 0
15 3134 G / C 19 NS A1020P EGFR 26 No 1 3
16 3475 C / A 21 NS H1133Q EGFR 29 No 11 4
17
a 3623 G / A 22 NS V1183M EGFR 30 No 0 2
18 3780 A / T 22 NS H1235L EGFR 31 No 3 2
19 3861 G / T 23 NS R1262L EGFR 32 Yes 1 0
20 3913 + 11 G / A 23 intron – – Yes 0 1
21 4424 G / A 24 NS A1450T LNR 2 Yes 1 0
22 4426 C / T 24 S A1450A LNR 2 Yes 1 0
23 4628 C / A 25 NS L1518M NOD Yes 1 0
24 4715 C / G 25 NS L1547V NOD Yes 1 1
25 5205 G / A 28 NS G1710D TMD Yes 1 0
26
a 5543 G / A 30 NS D1823N ANK 1 Yes 1 0
27 5602 T / C 30 S A1842A ANK 1 No 0 2
28 5930 G / A 32 NS V1952M ANK 5 Yes 2 3
29 6514 A / C 33 S A2146A LCR No 2 3
30
a 6645 C / T 33 NS A2190V LCR Yes 1 0
31
a 7045 C / T 33 30-UTR – – Yes 2 0
32 7138 C / T 33 30-UTR – – Yes 2 1
33 7245 A / C 33 30-UTR – – Yes 4 0
Non-synonymous SNPs detected only in individuals with severe white matter lesions are in bold.
a SNPs at CpG sites.
ANK = ankyrin repeat; cDNA = position of the SNP according to the NOTCH3 cDNA sequence, EGFR = epidermal growth factor-like repeat; LCR = low complexity region;
LNR = Lin12/Notch repeat; NOD = Notch domain; NS = non-synonymous mutation, prom: promoter; S = synonymous mutation; SNP ID = Identiﬁcation number of rare
SNP according to their position in the NOTCH3 gene; TMD = transmembrane domain; WML
+ = individuals with severe white matter lesions, WML
  = individuals with
normal MRI.
3392 | Brain 2011: 134; 3384–3397 H. Schmidt et al.(Arboleda-Velasquez et al., 2008). Notch3 is also involved in the
local vascular reaction to mechanical stress and to hypertension by
modulating vascular smooth muscle cell phenotype and by affect-
ing the balance between their proliferation and apoptosis (Morrow
et al., 2005, 2008). The observed hypertension dependent effect
of NOTCH3 variants is opposite to our earlier observations on the
angiotensinogen promoter B haplotype, which affects the risk for
white matter lesions independently of the presence of hyperten-
sion (Schmidt et al., 2001), probably by leading to an
over-expression of angiotensinogen in astrocytes (Schmidt et al.,
2004). Astrocytes and vascular smooth muscle cells are major con-
stituents of the neurovascular unit, and thus these ﬁndings support
a possible role of this structure in the development of age-related
white matter lesions.
Although the role of Notch3 in the development of age-related
cerebral small vessel disease can easily be envisioned, it remains
speculative how the described mutations alter its function. The
common SNPs associated with white matter lesions are synonym-
ous or intronic mutations and are in strong linkage disequilibrium
with each other. They are most probably not causal themselves
but rather mark the presence of yet undetected functional muta-
tion(s) in linkage disequilibrium. On the other hand, recent evi-
dence also suggests that synonymous mutations are able to alter
translational efﬁciency of a gene and, therefore, might be patho-
genic (Berleant et al., 2009).
Typically, CADASIL mutations are located within epidermal
growth factor-like repeats, they cluster in exons 3 and 4 and are
characterized by an uneven number of cysteine residues. It has
been argued that CADASIL mutations are most probably gain of
function mutations because they occur in regions with high se-
quence diversity and low evolutionary conservation and because
of their stereotyped nature (Donahue and Kosik, 2004) although a
recent report rather supports a hypomorphic nature at least for
two CADASIL mutations (Arboleda-Velasquez et al., 2011).
Possible new functions acquired by the mutations are misfolding
of the protein leading to aggregation or impaired protein–protein
interactions. Contrary to the stereotypic nature of CADASIL mu-
tations and their clustering in epidermal growth factor-like repeats,
the 42 different point mutations we detected in the normal elderly
are dispersed over the whole gene and the non-synonymous
changes lead to diverse amino acid substitutions. This ﬁnding is
more supportive for loss of function or hypomorphic mutations.
This is also in line with the observed gene dose effect for the risk
alleles. Non-cysteine (R75P) mutation in Korean and Japanese
CADASIL patients with granular osmiophilic material depositions
have been previously reported (Kim et al., 2006; Muzino et al.,
2008). These patients manifested multiple cerebral infarctions and
white matter lesions, which importantly did not extend to the
temporal lobe. The authors hypothesized that the R75P mutation
lead to a destabilization of the adjacent disulphide bridges be-
tween the cysteine residues. Recently, another non-cysteine
amino acid substitution, L1515P, has been described in a French
patient with cerebral small vessel disease lacking granular osmio-
philic material deposits, and Notch3 extracellular domain accumu-
lation. This mutation led to a destabilization of the Notch3
heterodimer and to a constitutive activation of the Notch3 recep-
tor (Fouillade et al., 2008). This mutation is located within a
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mutation detected in our cohort. Seven of the nine rare SNP car-
riers showed some ‘CADASIL-like’ clinical signs or MRI features,
which further supports functionality for the SNPs H170R, P496L,
L1518M and D1823N. Importantly, none of the rare SNP carriers
showed all characteristic symptoms of CADASIL, probably indicat-
ing the central role of cysteine mutations in this disease. Although
the individual with the D1823N did not present any CADASIL-like
signs, she had one of the most severe white matter lesions and
this mutation was predicted by all three in silico methods as func-
tional. The clinical characteristics of the R1262L carrier were simi-
lar, but for this mutation in silico analyses were ambiguous. In
addition to the deepening of our understanding about the patho-
genesis of age-related cerebral small vessel disease, knowledge of
Table 6 Predicted consequences of amino acid substitutions on protein function of the non-synonymous rare single nu-
cleotide polymorphisms observed only in individuals with severe white matter lesion by SIFT and Polyphen2 analysis and
with homology modelling and threading
Exon Amino acid change Domain Prediction SIFT Prediction polyphen2 Molecular modelling
3 R103Q EGFR 2 Tolerated Benign No signiﬁcant structural change
4 H170R EGFR 4 Affected Probably damaging Additional H-bond
9 P496L EGFR 12 Affected Possibly damaging Possible stronger van der Waals interactions
9 S497L EGFR 12 Tolerated Benign Possible change in EGFR folding
10 S502F EGFR 12 Tolerated Benign No signiﬁcant structural change
14 V764A EGFR 19 Affected Benign No signiﬁcant structural change
19 A1020P EGFR 26 Tolerated Benign Predicted structure is not reliable
21 H1133Q EGFR 29 Affected Benign No signiﬁcant structural change
22
a V1183M EGFR 30 Affected Possibly damaging Possible EGF-EGF interaction
22 H1235L EGFR 31 Tolerated Benign Predicted structure is not reliable
23 R1262L EGFR 32 Tolerated Benign may inﬂuence EGFR-EGFR folding
24 A1450T LNR 2 Tolerated Probably damaging Additional H-bond
25 L1518M NOD Affected Probably damaging Disruption of the leucine zipper pattern
25 L1547V NOD Tolerated Benign No signiﬁcant structural change
28 G1710D TMD Tolerated Possibly damaging No results
30 D1823N ANK 1 Affected Possibly damaging Possible ANK-ANK interaction
32
a V1952M ANK 5 Affected Probably damaging Additional H-bond
33 A2190V LCR Tolerated Benign No results
a SNPs not supported clinically but by all three bioinformatic tools; SNPs supported both clinically as well as by all three bioinformatic tools are given in bold.
ANK = ankyrin repeat; EGFR = epidermal growth factor-like repeat; prom: promoter; LCR = low complexity region; LNR = Lin12/Notch repeat; NOD = Notch domain;
TMD = transmembrane domain.
Figure 4 MRI ﬁndings suggestive of CADASIL in carriers of rare non-synonymous single nucleotide polymorphisms. Axial
ﬂuid-attenuated inversion recovery MRI images. (A) Subject 1350 with a V764A amino acid exchange showing a hyperintense rounded
area of signal hyperintensity in the temporal lobe directly adjacent to the temporal horn of the lateral ventricle (arrow). Although signal
changes at this location are not typically seen with age-related white matter changes, the abnormality can also not be considered speciﬁc
for CADASIL, because CADASIL lesions usually extend to the most anterior parts of the temporopolar white matter. (B) Subcortical lacunar
lesions which have been reported with CADASIL (van den Boom et al., 2002) are shown in the subinsular region and operculum of the
frontal lobe bilaterally. (C) demonstrates conﬂuent hyperintensity of the external capsule (arrow), a ﬁnding that has high sensitivity, but
low speciﬁcity in CADASIL (Markus et al., 2002).
3394 | Brain 2011: 134; 3384–3397 H. Schmidt et al.the mutation spectrum at NOTCH3 in the normal elderly should
also facilitate the interpretation of atypical non-cysteine mutations
in CADASIL diagnostics.
The strengths of our study are that it investigates for the ﬁrst
time a community based, normal elderly population for the pres-
ence of NOTCH3 gene variations and provides a comprehensive
list of SNPs in Europeans over the promoter, all exons and 30-
untranslated regions. Extensive phenotyping and the availability
of follow-up data in the Austrian Stroke Prevention Study cohort
allowed the investigation of the effect of mutations both
cross-sectionally and in longitudinal fashion. Further on the asso-
ciation of the common SNP, rs10404382, with the strongest effect
on white matter lesions in the original cohort was replicated in a
large sample of elderly individuals of European descent. Further
investigation of this SNP (or rs1043994 and rs10423702 that are
in strong linkage disequilibrium with it) in different cohorts and
ethnic groups are warranted to solidify their relevance in white
matter lesions risk. The functional relevance of the reported rare
mutations is still speculative and further studies on relatives of the
carriers as well as experimental studies are needed to establish
causality.
A potential problem of our study is that we have performed
multiple statistical tests in order to explore whether genetic vari-
ations at the NOTCH3 gene are relevant in age-related cerebral
small vessel disease. We investigated two primary phenotypes,
white matter lesions and lacunes and the secondary phenotype
white matter lesions progression. We investigated two statistical
models in the regression analyses, once we adjusted for age and
then for additional possible confounders including sex, hyperten-
sion, cardiac disease and diabetes to see if the effect size was
changed. We also tested nine common SNPs for associations
with white matter lesions and then followed up on the most sig-
niﬁcant four, which were highly correlated (R
240.9). Finally, we
explored the association in two subgroups by stratifying on hyper-
tension. In the results section, we did not adjust for multiple test-
ing, as both the outcome measures and the predictive SNPs are
correlated, and an adequate adjustment is therefore difﬁcult.
Although due to multiple testing, the possibility of false positive
ﬁndings in the discovery sample is enhanced, it should be noted
that the proportion of statistically signiﬁcant ﬁndings was much
45%, which one would expect by chance. Nevertheless, the most
important support for the assertion that ﬁndings in the Austrian
Stroke Prevention Study cohort are not due to chance comes from
the replication of our ﬁndings both in the individual cohorts AGES
and Cardiovascular Health Study as well as in meta-analyses of
large independent samples of stroke-free individuals within the
CHARGE consortium.
In summary, our study shows that the NOTCH3 gene is highly
variable in the elderly and that common variants at the NOTCH3
gene increase the risk of age-related white matter lesions in
the presence of hypertension. Additional investigations are
required to identify the mode of action of described NOTCH3
variants. Although conceivable, it needs to be explored as to
whether Notch3 signalling per se might be a relevant pathway
in the development of cerebral small vessel disease with
advancing age.
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